13.55
+1.24
+(10.07%)
At close: January 30 at 4:00:01 PM EST
13.71
+0.16
+(1.18%)
After hours: January 30 at 4:28:52 PM EST
Breakdown
12/31/2023
12/31/2022
Total Assets
26,000.00
16,645.00
Total Liabilities Net Minority Interest
33,973.00
23,945.00
Total Equity Gross Minority Interest
-7,973.00
-7,300.00
Total Capitalization
-7,973.00
-7,300.00
Common Stock Equity
-7,973.00
-7,300.00
Capital Lease Obligations
3,173.00
5,033.00
Net Tangible Assets
-7,973.00
-7,300.00
Working Capital
-19,398.00
-14,509.00
Invested Capital
-7,973.00
-7,300.00
Tangible Book Value
-7,973.00
-7,300.00
Total Debt
3,173.00
5,033.00
Share Issued
14,241.18
14,241.18
Ordinary Shares Number
14,241.18
14,241.18
12/31/2022 - 6/4/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ITOS iTeos Therapeutics, Inc.
7.68
+2.54%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
SNDX Syndax Pharmaceuticals, Inc.
14.21
-0.21%
NAMS NewAmsterdam Pharma Company N.V.
21.77
+4.76%
ACLX Arcellx, Inc.
67.58
+4.65%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
ALVR AlloVir, Inc.
9.41
-3.49%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
JANX Janux Therapeutics, Inc.
44.79
+5.36%
ANAB AnaptysBio, Inc.
17.42
0.00%